G01N 2333/523
Beta-chemokines
Official title: Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
G01N2333/523 (Beta-chemokines) appears on 51 US grants and 142 published applications in this corpus.
Search patents in G01N- Granted patents
- 51
- Published applications
- 142
- Assignees
- 101
- Inventors
- 290
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 6 |
| 2011 | 0 | 6 |
| 2012 | 3 | 7 |
| 2013 | 2 | 8 |
| 2014 | 2 | 8 |
| 2015 | 4 | 13 |
| 2016 | 1 | 16 |
| 2017 | 6 | 6 |
| 2018 | 6 | 6 |
| 2019 | 4 | 2 |
| 2020 | 6 | 9 |
| 2021 | 0 | 6 |
| 2022 | 1 | 5 |
| 2023 | 2 | 12 |
| 2024 | 2 | 6 |
| 2025 | 7 | 8 |
| 2026 | 4 | 13 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of treating an autoimmune disease with a human interleukin-3 (IL-3)-diphtheria toxin conjugate (DT-IL3)14 Jul 2026US 12,678,485 B2Stemline Therapeautics, Inc.
- Method for diagnosing and treating fibromyalgia24 Feb 2026US 12,560,614 B2Center for Immunology Science
- Methods of detecting and treating cerebral aneurysms17 Feb 2026US 12,553,904 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Method for measuring systemic chronic inflammaging6 Jan 2026US 12,517,135 B2Edifice Health, Inc.
- Anti-FAM19A5 antibodies and uses thereof9 Dec 2025US 12,492,246 B2Neuracle Science Co., Ltd.
- Multi-Analyte Rapid Diagnostic Test for Sepsis Using Novel Biomarkers and Quantum Dot Technology1 Oct 2026US 2026/0298921 A1Trimar Domestic Inc.
- Methods of treating endometriosis1 Oct 2026US 2026/0298926 A1Cedars-Sinai Medical Center
- Biomarkers of amyotrophic lateral sclerosis and uses thereof17 Sep 2026US 2026/0276655 A1
- Methods of predicting and treating immunotherapy adverse events based on immune cell populations16 Jul 2026US 2026/0202406 A1Board of Regents, The University of Texas System
- Molecular signatures to predict long-term liver fibrosis progression2 Jul 2026US 2026/0185169 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Methods of using biomarkers for predicting the outcome of an immunotherapy against cancer18US 9,389,235 B2Immatics Biotechnologies GmbH · 2016
- Methods of using biomarkers for predicting the outcome of an immunotherapy against cancer17US 8,669,063 B2Immatics Biotechnologies GmbH · 2014
- Method for diagnosing and treating acute joint injury10US 7,709,215 B2Cytonics Corporation · 2010
- Methods for determining responsiveness to an anti-CD47 agent9US 9,945,870 B2The Board of Trustees of the Leland Stanford Junior University · 2018
- Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast7US 10,018,637 B2Celgene International II SÀRL · 2018